🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Talkspace, Inc. TALK R2K

Healthcare · Health Information Services · United States
https://www.talkspace.com

Talkspace, Inc., together with its subsidiaries, operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States. The company provides psychotherapy and psychiatry services to treat various mental health conditions, such as depression, anxiety, trauma, and other fields of human challenges by operating an online platform for one-on-one therapy delivered through messaging, audio, and video channels. It serves health insurance plans and employee assistance programs, direct-to-enterprise customers, and individual subscribers. The company was formerly known as Groop Internet Platform Inc. and changed its name to Talkspace, Inc. in June 2021. The company was founded in 2012 and is headquartered in New York, New York.

READ MORE ›
$5.20
+63.01% 1Y

Market & Price

Market Cap
$871.07M
Current Price
$5.20
High / Low (52W)
$5.20 / $2.27
Beta
1.07

Valuation

Stock P/E
inf
Industry PE
23.65
Forward P/E
23.64
PEG Ratio
-
Book Value
$0.68
Price to Book
7.70
P/S
3.65
EV/EBITDA
96.71
Dividend Yield
-

Profitability & Returns

ROCE
2.68%
ROE
1.03%
ROA
2.03%
Profit Margin
0.49%
Op Margin
0.25%
EPS (Latest Qtr)
$-0.04
EPS (TTM)
$0.00

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
4.73
Current Ratio
4.84
Debt
$0
Total Assets
$134.86M
Current Assets
$111.06M
Working Capital
$93.67M

Ownership

Promoter Holding
5.20%
Chg in Prom Hold
-
FII / Inst Holding
82.42%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$786.85M
Total Revenue (TTM)
$238.37M
EBITDA
$8.14M
Free Cash Flow
$-3.11M
Operating Cash Flow
$5.36M
Shares Outstanding
167.51M
Gross Margin
39.16%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
24.16%
Profit 5Y
36.59%
Revenue (YoY)
18.20%
Earnings (YoY)
-

PROS

  • Compounding revenue at 24.2% over 5 years.
  • Profit CAGR of 36.6% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of inf.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 TALK Talkspace, Inc. R2K 5.20 inf $871.07M - 2.68% 1.03% 24.16% 36.59%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -17.88M21.50M27.16M30.98M26.36M30.15M29.84M29.33M33.34M35.65M38.65M45.42M46.06M-52.18M54.31M59.38M63.00M61.68M
Cost of Revenue ---------------28.79M30.92M34.74M36.08M36.06M
Gross Profit -12.31M15.09M17.34M19.29M14.17M15.02M14.55M14.60M16.75M17.81M18.85M21.73M20.95M-23.39M23.39M24.64M26.92M25.61M
Operating Expenses ---------------24.48M25.18M22.44M23.09M32.74M
Operating Income --641.00K2.40M-12.56M-27.56M25.23M21.21M21.07M19.85M9.04M-6.41M-5.18M-1.68M-3.49M--1.08M-1.79M2.20M3.83M-7.13M
EBITDA ----------------419.00K-1.07M2.88M4.65M-5.59M
Interest Expense --------------------
Pretax Income ---------------441.00K-465.00K3.28M5.12M-6.18M
Tax Provision ---------------123.00K76.00K25.00K350.00K124.00K
Net Income -7.90M-646.00K-2.69M-12.74M-30.44M1.50M-20.36M-23.02M-17.98M-8.76M-4.70M-4.41M-1.47M-474.00K-318.00K-541.00K3.25M4.76M-6.31M
Diluted EPS ---0.20-1.150.01-0.13-0.15-0.11-0.05-0.03-0.03-0.010.00-0.000.000.020.03-0.04
R&D Expense -2.40M2.20M2.96M4.78M4.28M5.04M5.58M6.07M5.35M4.17M4.18M3.74M2.09M2.30M2.84M2.56M1.78M-2.66M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 38.18M76.19M-119.57M150.04M187.59M228.87M
Cost of Revenue ---59.23M75.22M101.31M130.52M
Gross Profit 20.14M49.84M-60.34M74.83M86.28M98.35M
Operating Expenses ---137.36M98.03M90.78M95.20M
Operating Income -29.43M-21.98M--77.02M-23.21M-4.50M3.15M
EBITDA ----75.67M-21.92M-3.64M6.03M
Interest Expense -------
Pretax Income ----79.42M-18.96M1.24M8.37M
Tax Provision ---254.00K218.00K94.00K574.00K
Net Income -29.09M-22.37M--79.67M-19.18M1.15M7.79M
Diluted EPS --1.67-0.72-0.51-0.120.01-
R&D Expense 12.00M9.58M15.92M21.66M17.07M10.28M9.54M

Compounded Sales Growth

5 Years:24.16%
1 Year:18.20%

Compounded Profit Growth

5 Years:36.59%
1 Year:-

Stock Price Performance

1 Year:+63.01%
6 Months:+55.22%
3 Months:+7.88%
1 Month:+0.19%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --32.87M-156.25M142.22M138.68M134.86M
Current Assets ----152.56M139.80M130.18M111.06M
Cash & Equivalents 9.46M39.63M13.25M-138.54M123.91M76.69M37.35M
Inventory --------
Receivables ----9.64M10.17M9.64M16.06M
Total Liabilities --20.49M-28.72M23.57M21.28M17.85M
Current Liabilities --20.49M-27.32M21.65M19.02M17.40M
Long Term Debt --------
Total Debt --------
Total Equity -54.21M-79.60M-98.90M-127.54M118.65M117.39M117.02M
Shares Outstanding ----161.16M168.43M168.85M166.72M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -21.19M-15.18M--61.08M-16.39M11.29M8.53M
Investing Cash Flow -138.00K-11.30M--317.00K-141.00K-46.31M-28.88M
Financing Cash Flow 51.50M94.00K-1.68M1.90M-12.19M-19.00M
Capital Expenditure -138.00K-126.00K--350.00K-151.00K-5.44M-10.64M
Free Cash Flow -21.33M-15.30M--61.08M-16.39M5.84M-2.11M
Net Change in Cash ----59.71M-14.64M-47.22M-39.34M
Share Buybacks ---0011.00M17.20M

Ratios (Annual)

Figures in %.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 52.7%65.4%-50.5%49.9%46.0%43.0%
Operating Margin % -77.1%-28.9%--64.4%-15.5%-2.4%1.4%
Net Margin % -76.2%-29.4%--66.6%-12.8%0.6%3.4%
ROE % 36.5%22.6%--62.5%-16.2%1.0%6.7%
ROCE % --177.5%--59.7%-19.2%-3.8%2.7%

Shareholding Pattern

Insiders
5.20%
Institutions
82.42%
Public Float
86.94%

Top Institutional Holders

#Holder% HeldSharesValue
1 Hudson Executive Capital, LP 6.77% 11.34M $58.97M
2 Blackrock Inc. 6.21% 10.41M $54.11M
3 Balyasny Asset Management LP 5.29% 8.87M $46.11M
4 Deutsche Bank AG 4.25% 7.12M $37.03M
5 FIL LTD 3.99% 6.68M $34.75M
6 Vanguard Capital Management LLC 3.22% 5.40M $28.06M
7 Magnetar Financial LLC 2.54% 4.26M $22.14M
8 Alliancebernstein L.P. 2.30% 3.86M $20.06M
9 AWM Investment Company, Inc. 2.28% 3.83M $19.90M
10 Geode Capital Management, LLC 2.08% 3.48M $18.11M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for TALK

VentureBeat AI Fri, 16 Jan 2026

Listen Labs raises $69M after viral billboard hiring stunt to scale AI customer interviews

<p>Alfred Wahlforss was running out of options. His startup, <a href="https://listenlabs.ai/">Listen Labs</a>, needed to hire over 100 engineers, but competing against Mark Zuckerberg&#x27;s <a href="…

VentureBeat AI ue, 13 Jan 2026

Salesforce rolls out new Slackbot AI agent as it battles Microsoft and Google in workplace AI

<p><a href="https://www.salesforce.com/">Salesforce</a> on Tuesday launched an entirely rebuilt version of <a href="https://slack.com/help/articles/202026038-An-introduction-to-Slackbot">Slackbot</a>,…

CNBC Top News Fri, 29 May 2026

Software stocks wrap up best month since 2001 as talk of 'SaaSpocalypse' subsides

Snowflake and Okta both saw record stock pops this week as investors found favor in their AI software strategies.

CNBC Markets Fri, 29 May 2026

Software stocks wrap up best month since 2001 as talk of 'SaaSpocalypse' subsides

Snowflake and Okta both saw record stock pops this week as investors found favor in their AI software strategies.

CNBC Earnings Fri, 29 May 2026

Software stocks wrap up best month since 2001 as talk of 'SaaSpocalypse' subsides

Snowflake and Okta both saw record stock pops this week as investors found favor in their AI software strategies.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space